Bioprojet: Clinical Trials

5 trials sponsored by Bioprojet, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Completed 4, Terminated 1

Follow Bioprojet: new trials by email

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Determination the Abuse Potential of Pitolisant in Healthy, Non-Dependent Recreational Stimulant Users
Pitolisant, Placebos, Phentermine - Healthy, Drug Abuse
Phase 1CompletedBioprojet432017-03-152017-11-13
Study to Assess the Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]-Pitolisant in Healthy Male Volunteers
Pitolisant, [14C]-Pitolisant - Healthy Volunteers
Phase 1CompletedBioprojet82016-07-012016-10-11
First-time-in-man, to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BP1.5375
BP1.5375 suspension, Diphenhydramine, Placebo - Healthy Male Volunteers
Phase 1TerminatedBioprojet482014-10-012015-01-21
Racecadotril Suspension Linearity Study & Comparative Bioavailability Versus Granules
Racecadotril suspension, Racecadotril granules - Healthy Male Volunteers
Phase 1CompletedBioprojet532013-09-012014-02-25
Pharmacokinetics of BF2.649 in Renal Impairment
BF2.649 - Renal Impairment
Phase 1CompletedBioprojet252011-07-012013-04-12

Conditions studied

Renal Insufficiency (1)  ·  Substance-Related Disorders (1)

Interventions

pitolisant (3)  ·  Diphenhydramine (1)  ·  Phentermine (1)

Countries

France (2)  ·  Canada (1)  ·  Netherlands (1)

Top investigators

Litza McKenzie, MD (1)  ·  Michael B. McDonnell, MD (1)  ·  Thierry Duvauchelle, MD (1)  ·  Yves Donazzolo, MD (1)  ·  van Gerven Joop, MD (1)

Results publications

PMID 31626696

NIH funding

2016 (1)